EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARγ Signaling in Pulmonary Arterial Hypertension

Keytam S Awad iD, Shuibang Wang, Edward J Dougherty, Ali Keshavarz, Cumhur Y Demirkale, Zu Xi Yu, Latonia Miller, Jason M Elinoff iD, Robert L Danner iD

International Journal of Molecular Sciences · 15.05.2024 · 25 (10) · 5403

DOI: 10.3390/ijms25105403 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.05.2024. Verfasst von Keytam S Awad und 8 weiteren Autor:innen. Beteiligte Einrichtung: Critical Care Medicine Department, Clinical Center, NIH, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Signal Transduction, Bone Morphogenetic Protein Receptors, Type II, PPAR gamma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute R24, Cardiovascular Medical Research and Education Fund (CMREF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary arterial hypertension (PAH) is a progressive cardiopulmonary disease characterized by pathologic vascular remodeling of small pulmonary arteries. Endothelial dysfunction in advanced PAH is associated with proliferation, apoptosis resistance, and endothelial to mesenchymal transition (EndoMT) due to aberrant signaling. DLL4, a cell membrane associated NOTCH ligand, plays a pivotal role maintaining vascular integrity. Inhibition of DLL4 has been associated with the development of pulmonary hypertension, but the mechanism is incompletely understood. Here we report that BMPR2 silencing in pulmonary artery endothelial cells (PAECs) activated AKT and suppressed the expression of DLL4. Consistent with these in vitro findings, increased AKT activation and reduced DLL4 expression was found in the small pulmonary arteries of patients with PAH. Increased NOTCH1 activation through exogenous DLL4 blocked AKT activation, decreased proliferation and reversed EndoMT. Exogenous and overexpression of DLL4 induced BMPR2 and PPRE promoter activity, and BMPR2 and PPARG mRNA in idiopathic PAH (IPAH) ECs. PPARγ, a nuclear receptor associated with EC homeostasis, suppressed by BMPR2 loss was induced and activated by DLL4/NOTCH1 signaling in both BMPR2-silenced and IPAH ECs, reversing aberrant phenotypic changes, in part through AKT inhibition. Directly blocking AKT or restoring DLL4/NOTCH1/PPARγ signaling may be beneficial in preventing or reversing the pathologic vascular remodeling of PAH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktSignal TransductionBone Morphogenetic Protein Receptors, Type IIPPAR gammaReceptor, Notch1Pulmonary ArteryEndothelial CellsHumansAdaptor Proteins, Signal TransducingCalcium-Binding ProteinsPulmonary Arterial HypertensionMaleCell ProliferationHypertension, PulmonaryFemaleCells, Cultured

Stichwörter der Autor:innen

AKTBMPR2DLL4PPARγendothelial dysfunctionpulmonary arterial hypertensionsignal transductionvascular remodeling

Substanzen

Proto-Oncogene Proteins c-aktBone Morphogenetic Protein Receptors, Type IIPPAR gammaReceptor, Notch1DLL4 protein, humanBMPR2 protein, humanAdaptor Proteins, Signal TransducingNOTCH1 protein, humanCalcium-Binding ProteinsPPARG protein, human

Autor:innen und Institutionen

  • Critical Care Medicine Department, Clinical Center, NIH, Bethesda, MD 20892, USA.
  • Critical Care Medicine and Pulmonary Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892, USA.

ORCID-Profile: Keytam S Awad, Jason M Elinoff, Robert L Danner

Förderung

  • NHLBI NIH HHS
  • National Heart Lung and Blood Institute R24
  • Cardiovascular Medical Research and Education Fund (CMREF)
  • National Institutes of Health Clinical Center

Zitieren

APA

Awad, K. S., Wang, S., Dougherty, E. J., Keshavarz, A., Demirkale, C. Y., Yu, Z. X., Miller, L., Elinoff, J. M., & Danner, R. L. (2024). BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARγ Signaling in Pulmonary Arterial Hypertension. International Journal of Molecular Sciences, 25(10), 5403. https://doi.org/10.3390/ijms25105403

Vancouver

Awad KS, Wang S, Dougherty EJ, Keshavarz A, Demirkale CY, Yu ZX, et al. BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARγ Signaling in Pulmonary Arterial Hypertension. International Journal of Molecular Sciences. 2024;25(10):5403. doi:10.3390/ijms25105403

BibTeX
@article{Awad2024,
  author = {Awad, Keytam S and Wang, Shuibang and Dougherty, Edward J and Keshavarz, Ali and Demirkale, Cumhur Y and Yu, Zu Xi and Miller, Latonia and Elinoff, Jason M and Danner, Robert L},
  title = {BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARγ Signaling in Pulmonary Arterial Hypertension},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {10},
  pages = {5403},
  doi = {10.3390/ijms25105403}
}
Kostenlos starten →